KR101881175B1 - 구순포진, 음부포진, 및 대상포진의 재발을 조절하기 위한 폴리에틸렌 글리콜 조성물 - Google Patents

구순포진, 음부포진, 및 대상포진의 재발을 조절하기 위한 폴리에틸렌 글리콜 조성물 Download PDF

Info

Publication number
KR101881175B1
KR101881175B1 KR1020137002574A KR20137002574A KR101881175B1 KR 101881175 B1 KR101881175 B1 KR 101881175B1 KR 1020137002574 A KR1020137002574 A KR 1020137002574A KR 20137002574 A KR20137002574 A KR 20137002574A KR 101881175 B1 KR101881175 B1 KR 101881175B1
Authority
KR
South Korea
Prior art keywords
peg
herpes
recurrence
delete delete
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137002574A
Other languages
English (en)
Korean (ko)
Other versions
KR20130142992A (ko
Inventor
피터 비틴스
마르셀 랑게나우어
폴 마틴 셰러
Original Assignee
데비렉스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데비렉스 아게 filed Critical 데비렉스 아게
Publication of KR20130142992A publication Critical patent/KR20130142992A/ko
Application granted granted Critical
Publication of KR101881175B1 publication Critical patent/KR101881175B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020137002574A 2010-07-08 2011-07-08 구순포진, 음부포진, 및 대상포진의 재발을 조절하기 위한 폴리에틸렌 글리콜 조성물 Active KR101881175B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08
US61/362,329 2010-07-08
PCT/IB2011/001919 WO2012004669A1 (en) 2010-07-08 2011-07-08 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Publications (2)

Publication Number Publication Date
KR20130142992A KR20130142992A (ko) 2013-12-30
KR101881175B1 true KR101881175B1 (ko) 2018-07-23

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137002574A Active KR101881175B1 (ko) 2010-07-08 2011-07-08 구순포진, 음부포진, 및 대상포진의 재발을 조절하기 위한 폴리에틸렌 글리콜 조성물

Country Status (20)

Country Link
US (2) US9814743B2 (enExample)
EP (1) EP2563374B1 (enExample)
JP (1) JP5858994B2 (enExample)
KR (1) KR101881175B1 (enExample)
CN (1) CN103079574B (enExample)
AU (1) AU2011275458B2 (enExample)
CA (1) CA2803228C (enExample)
DK (1) DK2563374T3 (enExample)
ES (1) ES2442928T3 (enExample)
HR (1) HRP20140135T1 (enExample)
IL (1) IL223582A (enExample)
MX (1) MX2012014783A (enExample)
PL (1) PL2563374T3 (enExample)
PT (1) PT2563374E (enExample)
RS (1) RS53162B (enExample)
RU (1) RU2643763C2 (enExample)
SG (1) SG186937A1 (enExample)
SI (1) SI2563374T1 (enExample)
WO (1) WO2012004669A1 (enExample)
ZA (1) ZA201300177B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442928T3 (es) 2010-07-08 2014-02-14 Devirex Ag Composiciones de polietilenglicol para controlar las recidivas de herpes labialis, herpes genitalis y herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
CN104994889B (zh) 2013-02-19 2017-04-26 强生消费者公司 用于改善疤痕组织的外观和形成的方法及组合物
EP2803354B1 (de) * 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
WO2018095576A1 (en) * 2016-11-28 2018-05-31 Aicuris Anti-Infective Cures Gmbh Topical pharmaceutical formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide
AU2020268896B2 (en) 2019-05-03 2024-11-28 F. Hoffmann-La Roche Ag Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
EP4355297A1 (de) * 2020-04-30 2024-04-24 Ninoderm UG (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
KR20090111328A (ko) 2007-01-17 2009-10-26 데비렉스 아게 사이클로덱스트린 제형
ES2442928T3 (es) 2010-07-08 2014-02-14 Devirex Ag Composiciones de polietilenglicol para controlar las recidivas de herpes labialis, herpes genitalis y herpes zoster
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
The Journal of Infectious Diseases. 1982. Vol.146, No.1, pp.85-90.*

Also Published As

Publication number Publication date
AU2011275458A1 (en) 2013-02-28
IL223582A (en) 2017-12-31
JP2013530208A (ja) 2013-07-25
DK2563374T3 (da) 2014-01-20
EP2563374A1 (en) 2013-03-06
AU2011275458B2 (en) 2014-11-27
US20180055875A1 (en) 2018-03-01
HK1180969A1 (en) 2013-11-01
CN103079574A (zh) 2013-05-01
JP5858994B2 (ja) 2016-02-10
CN103079574B (zh) 2017-04-12
KR20130142992A (ko) 2013-12-30
US9814743B2 (en) 2017-11-14
ZA201300177B (en) 2014-03-26
RU2643763C2 (ru) 2018-02-05
US20130090389A1 (en) 2013-04-11
MX2012014783A (es) 2013-04-03
WO2012004669A1 (en) 2012-01-12
CA2803228C (en) 2019-03-12
CA2803228A1 (en) 2012-01-12
PT2563374E (pt) 2014-01-23
HRP20140135T1 (hr) 2014-03-28
PL2563374T3 (pl) 2014-04-30
EP2563374B1 (en) 2013-11-13
SI2563374T1 (sl) 2014-01-31
ES2442928T3 (es) 2014-02-14
RU2013100383A (ru) 2014-08-20
RS53162B (sr) 2014-06-30
SG186937A1 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
KR101881175B1 (ko) 구순포진, 음부포진, 및 대상포진의 재발을 조절하기 위한 폴리에틸렌 글리콜 조성물
US20190192539A1 (en) Composition for prevention or treatment of inflammatory skin diseases or severe pruritus comprising the aqueous solubilized ursodeoxycholic acid
US20100111883A1 (en) Cyclodextrin formulations
CN114423412A (zh) 包含大麻二酚的外用制剂、制备组合物的方法及其用途
CN104853759A (zh) 以gpcr19作用剂作为有效成分的过敏性皮肤疾病的预防或治疗用组成物
US20150118334A1 (en) Topical compositions for the treatment of chronic inflammatory skin disease
CN113521152B (zh) 抗皮炎组合物及其制备方法和用途
Raborn et al. Oral acyclovir in prevention of herpes labialis: a randomized, double-blind, multi-centered clinical trial
CA2884745A1 (en) Composition comprising plant phenols for preventing or reducing tewl and associated disorders and diseases
JP2006327967A (ja) フラボノイドを含有する皮膚外用剤
WO2013102885A1 (en) Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
JP2006327965A (ja) 皮膚外用剤とその適用
JP2024543626A (ja) 皮膚状態を改善するためのラクトバチルス・クリスパタス（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｃｒｉｓｐａｔｕｓ）細菌溶解物および／または細菌を含む組成物
KR20100124054A (ko) 더덕 추출물 또는 더덕 사포닌을 포함하는 히스타민 분비 억제용 조성물
HK1180969B (en) Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
KR100934691B1 (ko) 로즈마린산을 포함하는 로사시아 예방 또는 치료용 피부외용제 조성물
EP4640203A1 (en) Skin improvement compositions containing carnitine salicylate (ca-sa) as active ingredient
JP2006327966A (ja) 皮膚外用剤とその適用
WO2023018315A1 (ko) 개선된 세포 투과성 핵 수송 억제제를 포함하는 피부 보습 및 피부 진정용 화장료 조성물
WO2025224482A1 (es) Composición a base de acmella oppositifolia y de matricaria chamomilla
US20160058818A1 (en) Compositions and methods for relief from cold sores

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130130

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160628

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170519

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180329

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170519

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20180329

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20171120

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20160628

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20180520

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20180430

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20180329

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20171120

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20160628

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20180717

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20180717

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20210607

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20220608

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20230601

Start annual number: 6

End annual number: 6